Skip to main content
. 2022 Apr 6;43(3):103437. doi: 10.1016/j.amjoto.2022.103437

Table 3.

Characteristics of patients stratified by tracheostomy before and after propensity score matching.


Unmached

Matched(1:1)

Tracheostomy
(n = 27)
No tracheostomy (n = 64) P Tracheostomy
(n = 27)
No tracheostomy
(n = 27)
P
Age, median (IQR) 67 (55, 70) 68 (59.25, 73) 0.235 67 (55,70) 64 (55,73) 0.742
Male gender, n (%) 16(59.3%) 36(56.3%) 0.682 16(59.3%) 18(66.7%) 0.778
Duration from illness onset to intubation (days) 21 (13, 27) 19 (15,28) 0.814 21(13,27) 21(15, 28) 0.723
Leukocyte, median (IQR) 9.6 (7.28, 15.21) 15.42 (10.58, 19.55) 0.004 9.6(7.28, 15.21) 12.2(8.25, 17.59) 0.183
Neutrophil, median (IQR) 7.62 (6.25, 13.4) 13.76 (9.54, 18.10) 0.001 7.62(6.25,13.4) 11.34(7.57, 15.56) 0.085
lymphocyte, median (IQR) 0.71 (0.47, 0.79) 0.57 (0.42, 0.75) 0.328 0.71(0.47,0.79) 0.57(0.44, 0.76) 0.489
Procalcitonin, median (IQR) 0.58 (0.21, 1.26) 0.33 (0.11, 0.93) 0.192 0.58(0.21, 1.26) 0.36(0.1, 2.69) 0.533
Any comorbidity, n (%)
 Hypertension 16(59.3%) 26 (40.2%) 0.08 16(59.2%) 13(48.1%) 0.384
 Diabetes 10(37%) 14 (21.9%) 0.215 10(37%) 7(25.9%) 0.558
 Cardiovascular disease 5 (22.2%) 5 (7.8%) 0.155 5(22.2%) 4(14.8%) 1.000
 Malignancy 2(7.4%) 5 (7.8%) 1.000 2(7.4%) 2(7.4%) 1.000
 Cerebrovascular disease 9 (33.3%) 15 (23.4%) 0.796 9(33.3%) 8(29.6%) 1.000